Literature DB >> 26559379

Hereditary Renal Cell Carcinoma Syndromes: Clinical, Pathologic, and Genetic Features.

Adebowale J Adeniran1, Brian Shuch, Peter A Humphrey.   

Abstract

Renal cell carcinomas associated with syndromes of a heritable nature account for about 4% of all renal cell carcinomas. They are characterized by an earlier age of onset, and are often multicentric and bilateral. Some of these patients may fit into well-characterized kidney cancer syndromes, while many more may have a genetic component that is not fully recognized or understood. The presence of extrarenal clinical features may suggest a specific renal tumor susceptibility syndrome. Moreover, each syndrome is associated with specific renal pathology findings. Recognition of individuals and families with a high risk of renal neoplasia is important so that surveillance for renal tumors may be initiated. This manuscript reviews the clinical, pathological, and molecular features of hereditary renal cell carcinoma syndromes with emphasis on the morphologic features of these tumors and the molecular mechanisms of hereditary renal tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26559379     DOI: 10.1097/PAS.0000000000000562

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  13 in total

1.  Multiple unilateral subcapsular cortical hemorrhagic cystic disease of the kidney: CT and MRI findings and clinical characteristic.

Authors:  Kotaro Yoshida; Naoki Takahashi; Bernard F King; Akira Kawashima; Peter C Harris; Lynn D Cornell; Emilie Cornec-Le Gall; Dai Inoue; Ichiro Mizushima; Mitsuhiro Kawano; Eric Thervet; Paul René de Cotret; Vicente E Torres
Journal:  Eur Radiol       Date:  2019-02-26       Impact factor: 5.315

2.  Canadian Urological Association guideline for followup of patients after treatment of non-metastatic renal cell carcinoma.

Authors:  Wassim Kassouf; Leonardo L Monteiro; Darrel E Drachenberg; Adrian S Fairey; Antonio Finelli; Anil Kapoor; Jean-Baptiste Lattouf; Michael J Leveridge; Nicholas E Power; Frederic Pouliot; Ricardo A Rendon; Robert Sabbagh; Alan I So; Simon Tanguay; Rodney H Breau
Journal:  Can Urol Assoc J       Date:  2018-05-31       Impact factor: 1.862

3.  Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma.

Authors:  Steven C Smith; Kiril Trpkov; Ying-Bei Chen; Rohit Mehra; Deepika Sirohi; Chisato Ohe; Andi K Cani; Daniel H Hovelson; Kei Omata; Jonathan B McHugh; Wolfram Jochum; Maurizio Colecchia; Mitual Amin; Mukul K Divatia; Ondřej Hes; Santosh Menon; Isabela Werneck da Cunha; Sergio Tripodi; Fadi Brimo; Anthony J Gill; Adeboye O Osunkoya; Cristina Magi-Galluzzi; Mathilde Sibony; Sean R Williamson; Gabriella Nesi; Maria M Picken; Fiona Maclean; Abbas Agaimy; Liang Cheng; Jonathan I Epstein; Victor E Reuter; Satish K Tickoo; Scott A Tomlins; Mahul B Amin
Journal:  Am J Surg Pathol       Date:  2016-11       Impact factor: 6.394

Review 4.  Renal cell carcinoma.

Authors:  James J Hsieh; Mark P Purdue; Sabina Signoretti; Charles Swanton; Laurence Albiges; Manuela Schmidinger; Daniel Y Heng; James Larkin; Vincenzo Ficarra
Journal:  Nat Rev Dis Primers       Date:  2017-03-09       Impact factor: 52.329

Review 5.  Hereditary Renal Tumor Syndromes: Update on Diagnosis and Management.

Authors:  Sonia Gaur; Baris Turkbey; Peter Choyke
Journal:  Semin Ultrasound CT MR       Date:  2016-10-14       Impact factor: 1.875

Review 6.  Overview of the 2022 WHO Classification of Familial Endocrine Tumor Syndromes.

Authors:  Vania Nosé; Anthony Gill; José Manuel Cameselle Teijeiro; Aurel Perren; Lori Erickson
Journal:  Endocr Pathol       Date:  2022-03-13       Impact factor: 3.943

7.  The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing.

Authors:  Mariana M Cajaiba; Lisa M Dyer; James I Geller; Lawrence J Jennings; David George; Dawn Kirschmann; Stephen M Rohan; Nicholas G Cost; Geetika Khanna; Elizabeth A Mullen; Jeffrey S Dome; Conrad V Fernandez; Elizabeth J Perlman
Journal:  Cancer       Date:  2018-06-15       Impact factor: 6.860

Review 8.  [Hereditary renal tumors: More common than expected?].

Authors:  A Agaimy; A Hartmann
Journal:  Pathologe       Date:  2016-03       Impact factor: 1.011

9.  Quantification of contrast-uptake as imaging biomarker for disease progression of renal cell carcinoma after tumor ablation.

Authors:  Bruno R Tegel; Steffen Huber; Lynn J Savic; MingDe Lin; Bernhard Gebauer; Jeffrey Pollak; Julius Chapiro
Journal:  Acta Radiol       Date:  2020-03-26       Impact factor: 1.990

10.  Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement.

Authors:  Gennady Bratslavsky; Neil Mendhiratta; Michael Daneshvar; James Brugarolas; Mark W Ball; Adam Metwalli; Katherine L Nathanson; Phillip M Pierorazio; Ronald S Boris; Eric A Singer; Maria I Carlo; Mary B Daly; Elizabeth P Henske; Colette Hyatt; Lindsay Middleton; Gloria Morris; Anhyo Jeong; Vivek Narayan; W Kimryn Rathmell; Ulka Vaishampayan; Bruce H Lee; Dena Battle; Michael J Hall; Khaled Hafez; Michael A S Jewett; Christina Karamboulas; Sumanta K Pal; A Ari Hakimi; Alexander Kutikov; Othon Iliopoulos; W Marston Linehan; Eric Jonasch; Ramaprasad Srinivasan; Brian Shuch
Journal:  Cancer       Date:  2021-08-03       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.